NLS Pharmaceutics AG NLSP:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/02/21 EST
2.83quote price arrow down-0.16 (-5.35%)
Volume
37,532
52 week range
2.35 - 4.00

...

Loading . . .

KEY STATS

  • Open3.13
  • Day High3.13
  • Day Low2.77
  • Prev Close2.83
  • 52 Week High4.00
  • 52 Week High Date02/12/21
  • 52 Week Low2.35
  • 52 Week Low Date02/02/21
  • Market Cap33.37M
  • Shares Out11.79M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.31
  • P/E (TTM)-9.19
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.052M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-18.65%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest NLS Pharmaceutics AG News

There is no recent news for this security.

Latest NLSP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
Address
Alter Postplatz 2
Stans
6370
Switzerland